Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models
尼卡地平是一种推定的EED抑制剂,在临床前模型中对化疗耐药性前列腺癌具有高选择性和强效性。
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-023-02359-y
Li, Xin; Chen, Yanhua; Bai, Lijuan; Zhao, Rui; Wu, Yifei; Xie, Zhong-Ru; Wu, Jason M; Bowen, Nathan J; Danaher, Alira; Cook, Nicholas; Li, Dehong; Qui, Min; Du, Yuhong; Fu, Haian; Osunkoya, Adeboye O; Kucuk, Omer; Wu, Daqing